I am broadly interested in how individuals and families cope with and react to health-related adversity, particularly understanding the needs of ... following the loss of their child to cancer. Poster ...

OncoHost, a technology company transforming the approach to precision medicine for improved cancer patient outcomes, today announced its acceptance to present a scientific poster at the American ...

In conclusion, understanding the roles of NOTCH signaling in cancer resistance is critical for developing effective therapies. Future research should focus on distinguishing canonical and ...

This discovery—published today, Dec. 9, in Nature Biotechnology—could unveil an entirely different understanding of the origins of cancer within the body, as well as offer insight into new ...

Additionally, in the framework of a licensing agreement and a collaborative endeavor to support innovative research, Debiopharm and Oncodesign Services will present promising new data illustrating how ...

Zentalis Pharmaceuticals, Inc. announced that an abstract has been accepted for a poster presentation at the ... BRAF V600E mutant colorectal cancer, with data as of April 4, 2025.

At University College London, Professor Martin Widschwendter and his team have been studying how cancer starts, and it’s based on a relatively new understanding of ...

Morningstar brands and products Company Portfolio ...